A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
Providence Health & Services
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Inhibrx Biosciences, Inc
Seattle Children's Hospital
National Cancer Institute (NCI)
Providence Health & Services